Travere Therapeutics Q4 Adj EPS $(0.94) Beats $(1.26) Estimate, Sales $45.06M Beat $41.51M Estimate
Author: Benzinga Newsdesk | February 15, 2024 05:03pm
Travere Therapeutics (NASDAQ:
TVTX) reported quarterly losses of $(0.94) per share which beat the analyst consensus estimate of $(1.26) by 25.4 percent. This is a 23.68 percent decrease over losses of $(0.76) per share from the same period last year. The company reported quarterly sales of $45.06 million which beat the analyst consensus estimate of $41.51 million by 8.55 percent. This is a 19.35 percent decrease over sales of $55.87 million the same period last year.
Posted In: TVTX